Coronavirus Essential | Covaxin phase 3 trials efficacy at 81%, says Bharat Biotech; France looking to secure the Indian vaccine
Episode 3269, Mar 03, 2021, 01:10 PM
Tune in to the Coronavirus Essential podcast for all the latest updates on the pandemic.